Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : JNJ crawled date : 2021 - 09 - 17 save search
Global $400+ Mn Dry Eye Treatment Devices Market to 2028 Featuring Lumenis; ESW Vision; Johnson & Johnson; MiBo Medical; Alcon; and Sight Sciences
Published: 2021-09-17 (Crawled : 22:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
| Email alert
Add to watchlist
dry eye treatment eye device
LATINA Style Inc. Announces the 2021 LATINA Style 50 Report
Published: 2021-09-17 (Crawled : 19:00) - prnewswire.com
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
| Email alert
Add to watchlist
GM | News 4 d | $45.08 -0.04% 0.22% 15M
|
Consumer Durables
| Email alert
Add to watchlist
MCK | $535.42 0.64% 0.0% 420K
|
Distribution Services
| Email alert
Add to watchlist
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
| Email alert
Add to watchlist
MET | $72.72 0.69% 0.0% 2.1M
|
Finance
| Email alert
Add to watchlist
MMM | $92.02 -1.05% 0.0% 3.8M
|
Producer Manufacturing
| Email alert
Add to watchlist
F | News | $12.95 0.08% 2.55% 74M
|
Consumer Durables
| Email alert
Add to watchlist
STT 4 | $74.29 -0.13% 0.0% 8.6M
|
Finance
| Email alert
Add to watchlist
MAR | News | $244.04 1.82% 1.78% 2.3M
|
Consumer Services
| Email alert
Add to watchlist
WFC | $60.6 -0.56% -0.1% 20M
|
Finance
| Email alert
Add to watchlist
AFL | $84.28 0.63% 0.0% 2.4M
|
Finance
| Email alert
Add to watchlist
Research Roundup: Link Between Herpes Simplex Virus and Neurogenerative Disea...
Published: 2021-09-17 (Crawled : 17:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
research
Worldwide Short Bowel Syndrome Industry to 2026 - Development of Short Bowel Syndrome Drugs is at a Nascent Stage Presents Opportunities
Published: 2021-09-17 (Crawled : 17:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
NMTR | $0.0722 -42.97% -67.9% 10M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
drug syndros
BioSpace Movers & Shakers, Sept. 17
Published: 2021-09-17 (Crawled : 17:00) - biospace.com/
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.41%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: 0.0%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: 1.59%
H: 0.0%
C: 0.0%
PODD | $167.215 -0.03% -0.03% 650K
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
space spac
Research Roundup: Link Between Herpes Simplex Virus and Neurogenerative Diseases Gets More Support
Published: 2021-09-17 (Crawled : 17:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
disease research
Global Industry Analysts Predicts the World Natural and Organic Skin Care Products Market to Reach $9.7 Billion by 2026
Published: 2021-09-17 (Crawled : 16:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
skin
Research Roundup: Biogen’s Non-Opioid Pain Drug Hits Mark in Small Fiber Neuropathy
Published: 2021-09-17 (Crawled : 15:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
opioid drug research
Research Roundup: Biogen’s Non-Opioid Pain Drug Hits Mark in Small Fiber Neur...
Published: 2021-09-17 (Crawled : 14:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
opioid drug research
Janssen Presents Results from Phase 1b/2 NORSE Study in Patients with Metastatic or Locally Advanced Urothelial Carcinoma Treated with BALVERSA® (erdafitinib) in Combination with Cetrelimab, a PD-1 Inhibitor
Published: 2021-09-17 (Crawled : 12:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
phase 1 results phase 1b phase 2b urothelial carcinoma pd-1 inhibitor
Mat Bisher Joins DDB New York as Chief Creative Officer, Further Fueling the Power of Creativity within the New York Office
Published: 2021-09-17 (Crawled : 01:00) - prnewswire.com
OMC | $95.98 1.87% 0.0% 2.2M
|
Commercial Services
|
| O: 0.33%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.